Truepoint Inc’s Bausch Health BHC Stock Holding History

Truepoint Inc’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-25,000	Closed	-$504K	–	77
2016 Q2	$504K	Sell	25,000 -1,372	-5%	-$38.8K	0.06%	46
2016 Q1	$694K	Buy	+26,372	New	+$1.95M	0.09%	34

Other funds holding BHC

PSCM

Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Truepoint Inc's BHC Position: Q3 2016 in Review

Truepoint Inc sold out of Bausch Health (BHC) in Q3 2016, closing a stake of 25,000 shares — an estimated $504K sold.

Truepoint Inc first reported a position in BHC in Q1 2016 and held it in 2 quarters. The position peaked at $694K in Q1 2016. 345 funds tracked by Wall St. Rank hold BHC as of Q3 2016.

Truepoint Inc reported no remaining Bausch Health position as of Q3 2016 after selling out during the quarter.
Truepoint Inc sold 25,000 Bausch Health shares in Q3 2016, an estimated $504K.
Truepoint Inc first reported a position in Bausch Health in Q1 2016 and held it in 2 quarters.
Truepoint Inc's Bausch Health position peaked at $694K in Q1 2016.
345 funds tracked by Wall St. Rank held Bausch Health as of Q3 2016.

Based on Truepoint Inc's 13F filing for Q3 2016, filed 2 Nov 2016.